Anti-tumor activity of metformin: from metabolic and epigenetic perspectives
about
Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis.Regulation of SESAME-mediated H3T11 phosphorylation by glycolytic enzymes and metabolites.Downregulation of mitochondrial cyclooxygenase-2 inhibits the stemness of nasopharyngeal carcinoma by decreasing the activity of dynamin-related protein 1.Targeting MYC Dependence by Metabolic Inhibitors in CancerMetformin Inhibits Tumorigenesis and Tumor Growth of Breast Cancer Cells by Upregulating miR-200c but Downregulating AKT2 Expression.Metformin induces protein acetylation in cancer cells.Demographic Characteristics, Survival and Prognostic Factors of Early Breast Cancer Patients with Type 2 Diabetes Mellitus: A Hospital-Based Cohort StudyMetformin sensitizes lung cancer cells to treatment by the tyrosine kinase inhibitor erlotinib.Activation of Nrf2 signaling by natural products-can it alleviate diabetes?Fatty acid synthase (FASN) as a therapeutic target in breast cancer.Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents.Metformin, an Anti-diabetic Drug to Target Leukemia
P2860
Q30234811-910AF0E0-3B3A-4453-9B72-B0F4AAFCE82CQ33584813-923B5E1D-6C06-46BC-AA9E-C5FE4580330EQ33588277-89B168B8-4C5E-4428-BF86-5F600F665889Q33608493-0604F24C-05BB-41AF-ADD6-2890FA03B00BQ41396184-3727760A-AA57-4993-8715-E00FA2B063EFQ42335756-6E917983-FB6F-4223-A99D-EB59EC34E650Q47096644-49531ED2-4321-4CCF-9CBC-D44C59AAD4F5Q47205983-8BE8BC1E-D290-4CE3-9F9A-F378BA1BA7B9Q49385295-BA2130AD-A946-4FB7-ABDC-C2BAA0395577Q50044384-3A72D128-54E8-41CE-A443-97AB74E48FD5Q54940201-03626984-A91C-4D29-928C-84DA55DA6916Q58790135-60501702-0189-4D0C-A99D-733AABA432DC
P2860
Anti-tumor activity of metformin: from metabolic and epigenetic perspectives
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Anti-tumor activity of metformin: from metabolic and epigenetic perspectives
@ast
Anti-tumor activity of metformin: from metabolic and epigenetic perspectives
@en
Anti-tumor activity of metformin: from metabolic and epigenetic perspectives
@nl
type
label
Anti-tumor activity of metformin: from metabolic and epigenetic perspectives
@ast
Anti-tumor activity of metformin: from metabolic and epigenetic perspectives
@en
Anti-tumor activity of metformin: from metabolic and epigenetic perspectives
@nl
prefLabel
Anti-tumor activity of metformin: from metabolic and epigenetic perspectives
@ast
Anti-tumor activity of metformin: from metabolic and epigenetic perspectives
@en
Anti-tumor activity of metformin: from metabolic and epigenetic perspectives
@nl
P2093
P2860
P921
P356
P1433
P1476
Anti-tumor activity of metformin: from metabolic and epigenetic perspectives
@en
P2093
Chong Tong
Shanshan Li
Wuxiang Mao
Xiaolan Yu
Yansheng Zhai
P2860
P356
10.18632/ONCOTARGET.13639
P407
P5008
P577
2016-11-26T00:00:00Z
2017-01-17T00:00:00Z